NPI: 1558942011 · POWDERLY, KY 42367 · Rural Health Clinic/Center · NPI assigned 04/16/2021
Authorized official CLAY, DANYEL controls 20+ related entities in our dataset. Read more
| Authorized Official | CLAY, DANYEL (EXECUTIVE DIRECTOR REVENUE CYCLE) |
| NPI Enumeration Date | 04/16/2021 |
Other providers sharing the same authorized official: CLAY, DANYEL
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 3,939 | $82K |
| 2022 | 13,903 | $390K |
| 2023 | 12,318 | $371K |
| 2024 | 7,675 | $298K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11,230 | 9,150 | $427K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14,276 | 12,323 | $379K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1,001 | 927 | $110K |
| 87428 | 1,385 | 1,317 | $55K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,555 | 2,352 | $33K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 385 | 375 | $24K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 875 | 842 | $18K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 360 | 325 | $17K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 722 | 571 | $15K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 212 | 196 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,177 | 875 | $12K |
| 99443 | 152 | 111 | $8K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 385 | 375 | $6K |
| 71046 | Radiologic examination, chest; 2 views | 552 | 520 | $6K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 73 | 70 | $4K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 142 | 124 | $3K |
| 81025 | 434 | 292 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 113 | 90 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 44 | 39 | $2K |
| 77065 | Tomosynthesis, mammo | 27 | 25 | $1K |
| 76642 | 30 | 26 | $1K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 14 | 12 | $907.44 |
| 87210 | 283 | 193 | $904.64 | |
| 99442 | 36 | 28 | $855.61 | |
| 73630 | 66 | 56 | $716.30 | |
| 87807 | 57 | 55 | $617.56 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 137 | 130 | $520.26 |
| 76830 | Ultrasound, transvaginal | 12 | 12 | $487.58 |
| 72100 | 33 | 32 | $483.75 | |
| 90686 | 35 | 27 | $329.60 | |
| 73610 | 14 | 13 | $187.33 | |
| 3008F | 326 | 277 | $0.22 | |
| 2014F | 290 | 243 | $0.17 | |
| 1160F | 194 | 175 | $0.00 | |
| 1159F | 194 | 175 | $0.00 | |
| 81003 | 14 | 13 | $0.00 |